Teva Octreotide recall in Canada: potential quality issues
In plain language
This recall involves Teva Octreotide for injectable suspension sold in Canada. It's being recalled due to potential quality issues, including contamination or incorrect dosing. Stop using the product and speak to your healthcare professional for an alternative.
What to do
- Stop using the product immediately.
- Speak to your healthcare professional for an alternative or replacement.
- Return affected product(s) to the pharmacy for proper disposal.
- Seek medical attention if you have used this product and are experiencing symptoms or side effects.
- Contact Teva Canada Limited if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Teva Octreotide for injection 10 mg/vial - kit
UPC: 068510998460
Lot: 4401203R, 4401202, 4400915
Date codes: 30 Sep 2026, 31 Aug 2026, 31 Oct 2026
Teva Octreotide for injection 20 mg/vial - kit
UPC: 068510998477
Lot: 4501460, 4401309, 4401501, 4401231, 4401065
Date codes: 30 Sep 2026, 31 Mar 2027, 31 Oct 2026
Teva Octreotide for injection 30 mg/vial - kit
UPC: 068510998484
Lot: 4501296, 4401394, 4500804, 4500219, 4401208, 4500218, 4401207, 4400955, 4400918
Date codes: 28 Feb 2027, 30 Sep 2026, 31 Aug 2026, 31 Oct 2026
Why this matters
Potential quality issues including contamination or incorrect dosing
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the UPC code
The UPC is the barcode number on the packaging.
Affected UPCs: 068510998460, 068510998477, 068510998484
- 3
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 28 Feb 2027, 30 Sep 2026, 31 Aug 2026, 31 Mar 2027, 31 Oct 2026
- 4
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 4401203R, 4401202, 4400915, 4501296, 4401394, 4500804, 4500219, 4401208, 4500218, 4401207, 4400955, 4400918, 4501460, 4401309, 4401501, 4401231, 4401065
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential quality issues including contamination or incorrect dosing
What should consumers do?
Stop using the product immediately. Speak to your healthcare professional for an alternative or replacement. Return affected product(s) to the pharmacy for proper disposal. Seek medical attention if you have used this product and are experiencing symptoms or side effects. Contact Teva Canada Limited if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential quality issues including contamination or incorrect dosing
When was this product recalled?
This product was recalled on January 13, 2026.
Is the Teva brand affected by this recall?
Yes, Teva products are affected by this recall. This recall involves Teva Octreotide for injectable suspension sold in Canada. It's being recalled due to potential quality issues, including contamination or incorrect dosing. Stop using the product and speak to your healthcare professional for an alternative.